Tag: SPYRAL
SPYRAL HTN-ON MED study demonstrates meaningful clinical benefits consistent with other...
Medtronic has announced the six-month results from the full cohort of the SPYRAL HTN-ON MED clinical trial. The late-breaking data were presented at the...
US FDA approve new study of Medtronic’s Spyral renal denervation system
The FDA have given Medtronic approval to begin a clinical trial to evaluate the Symplicity Spyral renal denervation system in patients with hypertension who...
New renal denervation data show significant blood pressure reduction in patients...
Late-breaking SPYRAL HTN-ON MED study at EuroPCR indicates renal denervation lowers blood pressure in hypertensive patients in presence of blood pressure medication.
Medtronic has announced...
Could new study showing significant blood pressure reductions reignite interest in...
Medtronic has announced its intent to move forward with a new renal denervation pivotal trial following positive first results from a sham-controlled study in...
